Search

Your search keyword '"Vozzhaev A."' showing total 93 results

Search Constraints

Start Over You searched for: Author "Vozzhaev A." Remove constraint Author: "Vozzhaev A."
93 results on '"Vozzhaev A."'

Search Results

1. Potential barriers towards optimal medication adherence in out-patients with stable coronary artery disease

2. Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring

3. Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group

4. Multivariate analysis of medication adherence among outpatients with stable coronary artery disease

5. Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care

6. Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease

7. Critical aspects of the management of stable coronary artery disease in primary care practice or how to increase the efficacy of evidence-based pharmacological therapy?

8. Implementation of the concept of standard operating procedures into primary care practice: utopia or urgent need?

9. Medication adherence in patients with stable coronary artery disease in primary care

10. Medication adherence in patients with cardiovascular disease: current view of the problem

11. Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial

12. Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study

13. Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers

14. Lipid-lowering therapy in outpatients of different ages with coronary artery disease

15. Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?

16. The role of reference intervals of laboratory tests in early phase clinical research in healthy volunteers

17. The problem of over-volunteering in early phase clinical trials

18. Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)

19. Specific aspects of source medical documents in clinical studies on healthy volunteers

20. The role of pharmacist in early phase clinical research

21. Non-pharmacological secondary prevention of cardiovascular diseases in patients with stable angina at specialized ambulatory institution

22. FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

23. SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

24. Drug interchangeability: Clinical efficacy and safety

25. SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

28. Early phase clinical research as viewed by healthy volunteers

30. Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation

31. Some safety aspects of a new russian pegylated interferon-A medication 'ALGERON' (phase 1 clinical trial)

33. Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)

37. Comparison of medicamental secondary prevention of cardiovascular disease in ambulatory patients with myocardial infarction over a period of 2001-2006 (pharmacoepidemiological study)

38. Critical aspects of the management of stable coronary artery disease in primary care practice or how to increase the efficacy of evidence-based pharmacological therapy?

39. Medication adherence in patients with stable coronary artery disease in primary care

41. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

48. Drug interchangeability: Clinical efficacy and safety

49. SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

50. Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazim® (imiglucerase) in comparison with the reference product in healthy volunteers

Catalog

Books, media, physical & digital resources